Ketamine enantiomers in the rapid and sustained antidepressant effects
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Recent evidence has suggested that the N-methyl-D-aspartate receptor antagonist ketamine shows significant therapeutic effects in major depression and bipolar disorder. This effect is especially important in treatment-resistant depression and depression with suicidal ideation. In this review we explain the mechanism of action, drug efficacy, and the side effects of ketamine; the antidepressive effects of ketamine; the individual effects of ketamine isomers, R(–) ketamine and S(+) ketamine; the effects of the combination of ketamine with electroconvulsive therapy; and the possible use of ketamine in treating depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As mentioned previously in this review, there appear to be differences in the degree of adverse effects between the enantiomers of ketamine, although the two enantiomers have not yet been compared in a comprehensive head-to-head clinical study.27,34”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The S-enantiomer of ketamine (esketamine) is a more potent antagonist than R-ketamine at the phencyclidine site on the glutamate NMDA receptor,27–31 and has stronger analgesic potency than either R-ketamine or racemic ketamine.32”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“The S-enantiomer of ketamine (esketamine) is a more potent antagonist than R-ketamine at the phencyclidine site on the glutamate NMDA receptor,27–31 and has stronger analgesic potency than either R-ketamine or racemic ketamine.32”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 6×
“Furthermore, it is important to note that other antidepressants do not stimulate mTOR [Li et al. 2010].”
BackgroundInfluentialNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
McEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963 · cited 1×
“S ketamine has about a fourfold greater affinity for the NMDA receptor and greater anesthetic potency http://tpp.sagepub.com 189 [Domino, 2010].”
BackgroundR-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605
Domino, E. F., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ed09a2 · Cited by 520
Ketamine – More mechanisms of action than just NMDA blockade
Sleigh, J., Harvey, M., Voss, L., & Denny, B. (2014) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2014.03.002 · Cited by 434
Pharmacology of Ketamine Isomers in Surgical Patients
White, P. F., Ham, J., Way, W. L., & Trevor, A. (1980) · Anesthesiology · doi:10.1097/00000542-198003000-00008 · Cited by 425
Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans
Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710516 · Cited by 420 · cited 1×
“Ketamine is a desirable anesthetic because of its short half-life (180 min) and the lack of respiratory depression [Clemens et al. 1982].”
BackgroundCOMPARATIVE PHARMACOLOGY OF THE KETAMINE ISOMERS
WHITE, P. F., SCHÜTTLER, J., SHAFER, A., STANSKI, D. R., HORAI, Y., & TREVOR, A. J. (1985) · British Journal of Anaesthesia · doi:10.1093/bja/57.2.197 · Cited by 415
Vollenweider, F. X., Leenders, K. L., Øye, I., Hell, D., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00042-9 · Cited by 413
R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Zhang, J.-C., Li, S.-X., & Hashimoto, K. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.033 · Cited by 357
Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283
ECT in Treatment-Resistant Depression
Kellner, C. H., Greenberg, R. M., Murrough, J. W., Bryson, E. O., Briggs, M. C., & Pasculli, R. M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050648 · Cited by 279
Pro-and Anticonvulsant Effects of Anesthetics (Part I)
Modica, P. A., Tempelhoff, R., & White, P. F. (1990) · Anesthesia & Analgesia · doi:10.1213/00000539-199003000-00013 · Cited by 270
Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001119 · Cited by 253
A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences
Jansen, K. L. R. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400244 · Cited by 228
Iadarola, N. D., Niciu, M. J., Richards, E. M., Vande Voort, J. L., Ballard, E. D., Lundin, N. B., Nugent, A. C., Machado-Vieira, R., & Zarate, C. A. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315579059 · Cited by 201 · cited 2×
“In fact, a single subanesthetic dose infusion of ketamine has rapid and potent antidepressant effects in treatmentresistant major depression and bipolar depression [Iadarola et al. 2015].”
BackgroundNaughton, M., Clarke, G., O′Leary, O. F., Cryan, J. F., & Dinan, T. G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.014 · Cited by 190
Pfenninger, E. G., Durieux, M. E., & Himmelseher, S. (2002) · Anesthesiology · doi:10.1097/00000542-200202000-00022 · Cited by 189
Ghasemi, M., Kazemi, M., Yoosefi, A., Ghasemi, A., Paragomi, P., Amini, H., & Afzali, M. H. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.008 · Cited by 161
Okamoto, N., Nakai, T., Sakamoto, K., Nagafusa, Y., Higuchi, T., & Nishikawa, T. (2010) · The Journal of ECT · doi:10.1097/yct.0b013e3181c3b0aa · Cited by 149
Hevers, W., Hadley, S. H., Lüddens, H., & Amin, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5443-07.2008 · Cited by 128
Robson, M. J., Elliott, M., Seminerio, M. J., & Matsumoto, R. R. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.002 · Cited by 109
A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy
Rasmussen, K. G., Kung, S., Lapid, M. I., Oesterle, T., Geske, J. R., Nuttall, G. A., Oliver, W. C., & Abenstein, J. P. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.027 · Cited by 99
Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice
Tan, S., Lam, W. P., Wai, M. S. M., Yu, W.-H. A., & Yew, D. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043947 · Cited by 71
Lydic, R., & Baghdoyan, H. A. (2002) · Sleep · doi:10.1093/sleep/25.6.615 · Cited by 70
Involvement of the NMDA System in Learning and Memory
Rezvani, A. H. (2006) · Frontiers in neuroscience · doi:10.1201/9781420004335.ch4 · Cited by 67
MALIGNANT HYPERTHERMIA INDUCTION IN SUSCEPTIBLE SWINE FOLLOWING EXPOSURE TO ARDUAN
Williams, C. H., Farias, M., Marvasti, M. A., Knight, A. B., DiNardo-Ekery, D., DALY, I. W., & Zayed, I. (1990) · Anesthesia & Analgesia · doi:10.1213/00000539-199002001-00433 · Cited by 62
Ketamine anesthesia in electroconvulsive therapy.
Rasmussen, K. G., JARVIS, M. R., & Zorumski, C. F. (1996) · PubMed · Cited by 57
Isomerism and anaesthetic drugs
Calvey, T. N. (1995) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1995.tb04316.x · Cited by 54
Andrade, C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15f10026 · Cited by 49
Zielmann, S., Kazmaier, S., Schnüll, S., & Weyland, A. (1997) · Der Anaesthesist · doi:10.1007/pl00002464 · Cited by 49
Edwards, S. R., & Mather, L. E. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01287-5 · Cited by 46
Adams, H. A. (1997) · Der Anaesthesist · doi:10.1007/s001010050510 · Cited by 29
Jones, D. J., Nguyen, K. T., McLeish, M. J., Crankshaw, D. P., & Morgan, D. J. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00331-2 · Cited by 14
Hassamal, S., Spivey, M., & Pandurangi, A. K. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000104 · Cited by 13
Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways.
Lavenex (2000) · Pure Amsterdam UMC · doi:10.1002/1098-1063(2000)10:4 · Cited by 1
Research works printed but not linked: 3
- Rasmussen K., 1996, Convuls Ther, 12, 217
- 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A · doi:10.1002/1098-1063(2000)10:4<411::aid-hipo7>3.0.co;2-a
- Vuyk J., 2015, Miller’s Anesthesia, 821
Cited by
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
Molero, P., Ramos-Quiroga, J. A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., & Meana, J. J. (2018) · CNS Drugs · doi:10.1007/s40263-018-0519-3 · Cited by 280
Aleksandrova, L. R., Phillips, A. G., & Wang, Y. T. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160175 · Cited by 228
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Brain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 212
Pham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
Metadata
- Authors
- Muller, J., Pentyala, S., Dilger, J., & Pentyala, S.
- Affiliations
- Stony Brook University Hospital (US)
- Corresponding author
- Pentyala, Srinivas
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2016-03-10
- Volume
- 6
- Issue
- 3
- Pages
- 185-192
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC4910398
- OpenAlex
- W2320782138
- Cited by
- 122
- References
- 42
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 30 · 2023: 14 · 2022: 17 · 2021: 18 · 2020: 19 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 1
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, ketamine enantiomers, (R)-ketamine, esketamine, antidepressant effects, major depressive disorder, bipolar disorder, treatment-resistant depression, suicidal ideation, NMDA receptor antagonists, mechanism of action, adverse drug reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.